Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 7442778 Modified Fc molecules

Patent 7442778 was granted and assigned to Amgen on October, 2008 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Amgen
Amgen
0
Date Filed
September 23, 2005
0
Date of Patent
October 28, 2008
0
Patent Application Number
11234731
0
Patent Citations Received
‌
US Patent 11713358 Chimeric polypeptide assembly and methods of making and using the same
0
‌
US Patent 11873330 Cysteine engineered antibodies and conjugates
0
‌
US Patent 11788066 Antibody conjugates and methods of making and using the same
‌
US Patent 12071456 Extended recombinant polypeptides and compositions comprising same
0
‌
US Patent 11981744 Chimeric polypeptide assembly and methods of making and using the same
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
7442778
0
Patent Primary Examiner
‌
Sheela J. Huff
0

Find more entities like US Patent 7442778 Modified Fc molecules

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.